Wellspect AB
Explore this company’s associated devices, FDA decisions and regulatory history.

Wellspect AB
- Regulatory records
- 2
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 2 FDA records to the applicant name Wellspect AB. The collection includes 2 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Apr 24, 2026 to Jul 17, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code EZD appears in 2 of the 2 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: Amniogatan 1, P.O.Box 14, Se-431 51 Sweden, Mölndal, SE. Recorded on K261658, decision dated Jul 17, 2026.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LoFric Origo Pro CoudéK261658 | Wellspect AB | 510(k) clearance | Jul 17, 2026 | FDA |
LoFric Elle ProK260999 | Wellspect AB | 510(k) clearance | Apr 24, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.

